PIM3 and liver cancer: In addition, it is reasonable to conclude that Pim-3 upregulation mediated by a low miR-936 expression promotes sorafenib resistance in liver cancer by inhibiting ferroptosis, in which the activation of the ANKRD18A/Src/NRF2 pathway, especially the transcriptional activity of NRF2, is essential.